title: A rapid indirect method to determine the plasma concentrations of neutral endopeptidase inhibitors.
abstract: The selection of therapeutic agents for clinical development is principally based upon pharmacodynamic and pharmacokinetic criteria. Although many compounds are routinely tested in pharmacologic assays, direct pharmacokinetic assessment is difficult and not applicable to a large number of agents. Therefore, we have developed a rapid indirect method based on enzyme inhibition for determining the unbound concentration of NEP 24.11 inhibitors in rat plasma. In the present study, drug levels of compounds from three different classes of NEP 24.11 inhibitors: mercaptoalkyl, carboxyalkyl and aminophosphonates were compared. Studies were carried out in conscious, unrestrained rats. Arterial blood samples were obtained 10, 30, 60, 120, and 240 min after drug administration at 10 mg/kg i.v. or 30 mg/kg p.o. The blood was collected in EDTA and plasma prepared immediately. Protein bound NEP inhibitor was separated from plasma by centrifugation through an ultrafiltration membrane. Following acidification and serial dilution, the concentration of unbound inhibitor was determined in the plasma ultrafiltrate using the in vitro assay for NEP 24.11 inhibition. The results of this study indicated that the mercaptoalkyl inhibitor thiorphan was cleared rapidly from plasma, whereas, the plasma concentrations of the carboxyalkyl inhibitor CGS 23880A (UK-69,578), and the plasma concentrations of the aminophosphonate, CGS 24128, were maintained at high levels for at least 4 hours. Furthermore, the ratio of the NEP inhibitor concentration/IC50 value correlated well with the pharmacologic activity of these compounds.
authors.affiliation: Research Department, Ciba-Geigy Corporation, Summit, NJ 07901, USA.
authors.forename: R D
authors.initials: RD
authors.lastname: Ghai
authors.forename: S
authors.initials: S
authors.lastname: De Lombaert
authors.forename: G M
authors.initials: GM
authors.lastname: Ksander
authors.forename: C
authors.initials: C
authors.lastname: Berry
authors.forename: Y
authors.initials: Y
authors.lastname: Sakane
authors.forename: A J
authors.initials: AJ
authors.lastname: Trapani
mesh_terms: D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood; D003509:Cyclohexanecarboxylic Acids / Q000097:blood*; D004791:Enzyme Inhibitors / Q000097:blood; D007672:Kidney Cortex / Q000201:enzymology; D008297:Male; D008722:Methods; D015260:Neprilysin / Q000037:antagonists & inhibitors* / Q000097:blood*; D063065:Organophosphonates / Q000097:blood*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015244:Thiorphan / Q000097:blood*; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D003509:Cyclohexanecarboxylic Acids; D004791:Enzyme Inhibitors; D063065:Organophosphonates; D015091:beta-Alanine; C087656:CGS 24128; C060942:candoxatrilat; D009320:Atrial Natriuretic Factor; D015244:Thiorphan; D015260:Neprilysin